Trials / Conditions / ELGAN (22-28SA)
ELGAN (22-28SA)
3 registered clinical trials studyying ELGAN (22-28SA) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correl NCT07273643 | University Hospital, Montpellier | — |
| Not Yet Recruiting | Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants NCT07058025 | Ottawa Hospital Research Institute | Phase 2 |
| Not Yet Recruiting | Cardiovascular Immaturity in Extremely Low Gestational Age Newborns: a Fundamental Prospective Study NCT06737965 | University Hospital, Montpellier | — |